Peptide safety
"Is this safe?" is the right first question. These articles look at peptide safety — what data actually exists for peptides and GLP-1 medications: what trials measured, what has only been studied in animals, how sourcing and compounding affect quality, and which red flags matter when you read claims online.
The prescription requirement exists precisely for this: a licensed provider weighs your health history before anything ships — and can say no. The same standard applies across the site: what a study measured, in whom, and for how long.
365 articles on this topic
-
CJC-1295 Ipamorelin News: October 2026
The quarter brought a new WADA list, online-product notices and an evidence review. The two molecules still have different FDA records and limited human outcome data.
-
What Is Bacteriostatic Water? Meaning and Safety
Bacteriostatic water contains a preservative that limits bacterial growth. The medication’s instructions decide whether it is the right mixing liquid.
-
Egrifta Prescribing Information, Explained
Egrifta WR’s label covers one HIV-related use, a daily dose, four contraindications, monitoring, side effects, and product-specific storage. WR and SV directions cannot be swapped.
-
IGF-1 Levels by Age: Reading Your Lab Result
IGF-1 levels by age usually decline after early adulthood. Your lab's range puts the number in context; trial increases aren't treatment targets.
-
10 Questions to Ask Before BPC-157
Ten questions explain what a BPC-157 visit needs to cover, from medical history and evidence limits to sport testing and follow-up.
-
Sermorelin Myths: 10 Claims Checked
Sermorelin can stimulate growth-hormone release. Ten familiar claims about aging, muscle, sleep and safety go further than the human studies support.
-
1977 Nobel Prize in Medicine: Peptide Discoveries
Three scientists shared the prize for finding the brain’s hormone messages and making tiny hormone levels measurable. Here’s how that history connects to today’s prescriptions.
-
STEP 5 Trial Results: Semaglutide at Two Years
In STEP 5, average weight loss was 15.2% with semaglutide versus 2.6% with placebo at two years. The plateau, side effects and two calculations explain what held up.
-
Who Discovered Ghrelin? Kojima and Kangawa
Masayasu Kojima, Kenji Kangawa and colleagues identified ghrelin in 1999. Earlier peptide and receptor discoveries set up the finding; appetite studies followed.
-
Thymosin Alpha 1 News: October 2026 Update
New studies broaden the research questions, while U.S. status remains unchanged. Here is what the July–September quarter adds to a prescribing conversation.
-
Semaglutide and Gout: It Isn't a Gout Treatment
Semaglutide may lower uric acid, but fewer gout attacks remain unproven. New findings make a gout history and a flare plan part of the prescribing conversation.
-
Semaglutide Knee Osteoarthritis: What STEP 9 Found
In STEP 9, adults with obesity had greater average knee-pain and weight reductions with semaglutide. The trial did not establish cartilage repair.
-
Tesamorelin Fatty Liver Trial: What It Found
A 12-month trial found less liver fat and less worsening of scarring with tesamorelin. Its 61 participants had HIV, a virus that weakens the immune system, which limits what the findings mean for everyone else.
-
What Is Food Noise? Meaning and GLP-1 Evidence
Food noise means intrusive food thoughts that are hard to set aside. GLP-1 studies offer evidence about cravings and eating control, while the term itself is still being defined.
-
Epitalon Telomeres: What the Studies Actually Show
The claim comes from cells studied outside the body. Those findings haven't established a longer or healthier life for people taking epitalon.
-
TB-500 Myths: Ten Claims Checked Against Studies
TB-500's benefits in humans have not been established. Ten common claims get graded against the actual molecule, study and outcome behind them.
-
Tirzepatide and Thyroid: Levothyroxine Checks
An underactive thyroid doesn't automatically rule out tirzepatide. Weight loss and changes in tablet absorption can make a thyroid-dose review worthwhile.
-
What Is a Bulk Drug Substance? API, Explained
A bulk drug substance is the active ingredient before it becomes a finished medicine. Its exact chemical form, source and batch testing matter.
-
10 Questions to Ask Before PT-141
A PT-141 visit starts with fit and safety. These ten questions clarify the evidence, medical history, side effects, and follow-up plan.
-
Does Semaglutide Cause Thyroid Cancer?
Human studies have not established that semaglutide causes thyroid cancer. The warning comes from tumors in rats and mice, and specific cancer histories rule out use.
Page 2 of 19 · 365 articles